Pantheon Investment Group’s Bristol-Myers Squibb BMY Stock Holding History

Pantheon Investment Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1.75M	Sell	28,335 -948	-3%	-$55.6K	1.38%	22
2021 Q3	$1.74M	Buy	29,283 +398	+1%	+$26.2K	1.49%	24
2021 Q2	$1.93M	Sell	28,885 -1,446	-5%	-$94.3K	1.62%	20
2021 Q1	$1.92M	Buy	30,331 +3,034	+11%	+$189K	1.84%	15
2020 Q4	$1.69M	Sell	27,297 -4,095	-13%	-$252K	1.85%	15
2020 Q3	$1.89M	Buy	31,392 +3,072	+11%	+$185K	2.25%	12
2020 Q2	$1.67M	Buy	28,320 +199	+0.7%	+$11.9K	2.09%	15
2020 Q1	$1.57M	Buy	28,121 +8,083	+40%	+$494K	2.36%	15
2019 Q4	$1.28M	Buy	+20,038	New	+$1.15M	1.21%	29

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pantheon Investment Group's BMY Position: Q4 2021 in Review

Pantheon Investment Group reduced its Bristol-Myers Squibb (BMY) stake by 3.2% in Q4 2021, selling an estimated $55.6K and leaving 28,335 shares worth $1.75M. The position accounts for 1.38% of the portfolio, ranked #22.

Pantheon Investment Group first reported a position in BMY in Q4 2019 and has held it in 9 quarters since. The position peaked at $1.93M in Q2 2021. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Pantheon Investment Group held 28,335 shares of Bristol-Myers Squibb worth $1.75M as of Q4 2021.
Pantheon Investment Group sold 948 Bristol-Myers Squibb shares in Q4 2021, an estimated $55.6K.
Bristol-Myers Squibb made up 1.38% of Pantheon Investment Group's portfolio in Q4 2021, its #22 holding.
Pantheon Investment Group first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 9 quarters since.
Pantheon Investment Group's Bristol-Myers Squibb position peaked at $1.93M in Q2 2021.
2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Pantheon Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.